Skip to content
Contact us

Your cryo-EM ducks in a row

Consultancy and solutions for cryo-EM in drug discovery.

Cryo-EM ducks in a row

For drug discovery, vendors, and VCs 

Empowering the cryo-EM biotech landscape from end users to investors.

Biotech

Biotech & Pharma

  • Support of in-house platforms and outsourcing to CROs.
  • Gene-to-structure consultancy and solutions.
  • Partners for structure-to-drug.
  • Early access to innovation.
Cryo-EM solutions

Cryo-EM vendors

  • Scientist-to-scientist marketing and business development.
  • Customer-centric and holistic product strategy.
  • Flexibility for strategic collaborations, application development, and ecosystem access.
Biotech VCs

Venture Capital

  • Scientific consulting and networking for company creation.
  • Scientific due diligence and proof of concepts.
  • Development and integration of rational drug design platforms.

End-to-end workflows

Transforming point solutions into an encompassing cryo-EM success equation.

Full cryo-EM platform development

Next-gen applications

EM-grade protein

Grid preparation

Electron microscopy

Data processing

Rational drug design

Applications
Protein
Freeze
EM1
Processing-&-Data
CADD

  • Reduce time-to-structure and costs.

  • Improve resolution and structure throughput.

  • Maximize impact on must-win programs.

Duck ecosystem

Exclusive and seamless: Ecosystem-wide collaboration

• Benefit from alliances with best-in-breed solutions.

• Harnessing collective strengths to accelerate innovation.

• Conflict-free collaborations for trust and transparency.

Across targets and modalities

Membrane-protein
Membrane proteins
Small molecules
Small-molecule
Small-protein
Small targets
Antibodies
Biologics
Large-protein1
Large complexes
New modalities
New-modalities
  • Membrane proteins including GPCRs, ion channels, and solute transporters.
  • Small targets and large multi-subunit complexes.
  • Small molecules, antibodies, and emerging modalities including targeted protein degraders.